Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Top Cited Papers
Open Access
- 8 January 2009
- journal article
- review article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 7 (1) , 5
- https://doi.org/10.1186/1477-7819-7-5
Abstract
Background: Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cancer, gastric cancer, gynecologic malignancies or peritoneal mesothelioma is a common sign of advanced tumor stage or disease recurrence and mostly associated with poor prognosis. Methods and results: In the present review article preoperative workup, surgical technique, postoperative morbidity and mortality rates, oncological outcome and quality of life after CRS and HIPEC are reported regarding the different tumor entities. Conclusion: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising combined treatment strategy for selected patients with peritoneal carcinomatosis that can improve patient survival and quality of life. The extent of intraperitoneal tumor dissemination and the completeness of cytoreduction are the leading predictors of postoperative patient outcome. Thus, consistent preoperative diagnostics and patient selection are crucial to obtain a complete macroscopic cytoreduction (CCR-0/1).Keywords
This publication has 54 references indexed in Scilit:
- Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapyEuropean Journal of Surgical Oncology, 2009
- Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II TrialJournal of Clinical Oncology, 2008
- Monitoring Health Outcomes Following Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal CarcinomatosisAnnals of Surgical Oncology, 2007
- Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapyInternational Journal of Hyperthermia, 2007
- Early Postoperative Intraperitoneal Chemotherapy Following Cytoreductive Surgery in Patients with Very Advanced Gastric CancerAnnals of Surgical Oncology, 2006
- Quantitative prognostic indicators of peritoneal dissemination of gastric cancerPublished by Elsevier ,2006
- Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapyEuropean Journal of Surgical Oncology, 2005
- Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix CancerAnnals of Surgical Oncology, 2001
- Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosisEuropean Journal of Surgical Oncology, 2001
- Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgeryCancer, 1997